Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection

TerminatedOBSERVATIONAL
Enrollment

241

Participants

Timeline

Start Date

December 9, 2014

Primary Completion Date

August 14, 2017

Study Completion Date

August 14, 2017

Conditions
Chronic Hepatitis B
Interventions
DRUG

GS-4774

Exposure of interest for participants who received GS-4774 (administered as a subcutaneous injection) in a previous Gilead study for chronic hepatitis B virus infection.

DRUG

GS-9620

Exposure of interest for participants who received GS-9620 (tablets administered orally) in a previous Gilead study for chronic hepatitis B virus infection.

DRUG

Tenofovir disoproxil fumarate (TDF)

Exposure of interest for participants who received TDF (tablets administered orally) in a previous Gilead study for chronic hepatitis B virus infection.

Trial Locations (37)

Unknown

Kaiser Permanente, Sacramento

Kaiser Permanente, San Diego

Kaiser Permanente, San Francisco

Silicon Valley Research Institute, San Jose

University of Miami, Miami

The Queen's Medical Center, Honolulu

Northwestern University, Chicago

Digestive Disease Associates, PA, Baltimore

Tufts Medical Center, Boston

University of Michigan, Ann Arbor

Henry Ford Hospital, Detroit

St. Louis University, St Louis

Medical Procare, PLL, Flushing

Northwell Health, Manhasset

Xiaoli Ma, PC, Philadelphia

Bon Secours St. Mary's Hospital of Richmond, Newport News

Royal Prince Alfred Hospital, Camperdown

University of Calgary, Calgary

Gordon and Leslie Diamond Health Care Centre, Vancouver

Liver and Intestinal Research Centre, Vancouver

University of Manitoba, Winnepeg

Toronto General Hospital, Toronto

Princess Margaret Hospital, Lai Chi Kok

Prince of Wales Hospital, Shatin

Nirmal Hospital Private Limited, Surat

Midas Multispecialty Hospital Private Limited, Nagpur

Dept. of Hepatology, School of Digestive & Liver Diseases, Kolkata

IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo

Azienda Ospedaliera Universitaria Pisana, Caianello

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

Azienda Ospedaliera Universitaria di Parma, Parma

Auckland City Hospital, Auckland

Pusan National, Busan

Korea University, Seoul

Samsung Medical Center, Seoul

Seoul National University Bundang Hospital, Seoul

Yonsei University, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY